In summary, we demonstrated for the first time that Rev-erbα was recruited to promoters of PFKFB3 and G6PD genes, thereby inhibiting glycolytic flux and the PPP, and subsequent proliferation in in vitro human gastric cancer cells. This evidence concerns the gene PFKFB3 and gastric cancer.